Roxithromycin attenuates acid-induced cough and water-induced bronchoconstriction in children with asthma

Journal of Asthma

Volumn 34, Issue 3, 1997, Pages 211-217

  Shimizu, Toshio ^a   Kato, Masahiko ^a   Mochizuki, Hiroyuki ^a   Takei, Katsumi ^a   Maeda, Shozo ^a   Tokuyama, Kenichi ^a   Morikawa, Akihiro ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Acetic acid; Bronchial hyperresponsiveness; Childhood asthma; Cough threshold; Distilled water; Roxithromycin

Indexed keywords

ACETIC ACID; MACROLIDE; ROXITHROMYCIN; THEOPHYLLINE; WATER;

ADOLESCENT; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; COUGHING; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PROVOCATION TEST; SCHOOL CHILD; THEOPHYLLINE BLOOD LEVEL;

EID: 0030923130     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.3109/02770909709068191     Document Type: Article

References (40)

1. Spector SL, Katz FH, Farr RS: Troleandomycin: Effectiveness in steroid-dependent asthma and bronchitis. J Allergy Clin Immunol 54:367-379 (1974).
2. Itkin IH, Menzel ML: The use of macrolide antibiotics substances in the treatment of asthma. J Allergy 45:146-162 (1970).
3. LaForce CF, Szefler SJ, Miller MF, Ebling W, Brenner M: Inhibition of methylprednisolone elimination in the presence of erythromycin therapy. J Allergy Clin Immunol 72:34-39 (1983).
4. Cott GR, Cherniack RM: Steroids and "steroid-sparing" agents in asthma. N Engl J Med 318:634-636 (1988).
5. Zarowitz BJM, Szefler SJ, Lasezkay GM: Effect of erythromycin base on theophylline kinetics. Clin Pharmacol Ther 29:601-605 (1981).
6. Rosenberg SM, Gerhand H, Grunstein MM, Schramm CM: Use of TAO without methylprednisolone in the treatment of severe asthma. Chest 100:849-850 (1991).
7. Miyatake H, Taki F, Taniguchi H, Suzuki R, Takagi K, Satake T: Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest 99:670- 673 (1991).
8. Esterly NB, Furey NL, Flanagan LE: The effect of antimicrobial agents on leukocyte chemotaxis. J Invest Dermatol 70:51-55 (1978).
9. Nelson S, Summer WR, Terry PB, Warr GA, Jakob GJ: Erythromycin-induced suppression of pulmonary antibacterial defenses. Am Rev Respir Dis 136:1207- 1212 (1987).
10. Miyachi Y, Yoshioka A, Niwa Y: Effect of antibiotics on the generation of reactive oxygen species. J Invest Dermatol 86:499-453 (1986).
11. Shimizu T, Kato M, Mochizuki H, Tokuyama K, Morikawa A, Kuroume T: Roxithromycin reduces the degree of bronchial hyperresponsiveness in children with asthma. Chest 106:458-161 (1994).
12. Mochizuki H, Shimizu T, Maeda S, Tokuyama K, Morikawa A, Kuroume T: Relationship between ultrasonically nebulized distilled water-induced bronchoconstriction and acid-induced cough in asthmatic children. J Allergy Clin Immunol 96:193- 199 (1995).
13. Mochizuki H, Shimizu T, Morikawa A, Kuroume T: Inhaled diuretics attenuate acid-induced cough in children with asthma. Chest 107:413-417 (1995).
14. Mitsuhashi M, Mochizuki H, Tokuyama K, Morikawa A, Kuroume T: Hyperresponsiveness of cough receptors in patients with bronchial asthma. Pediatrics 75:855-858 (1985).
15. Mochizuki H, Tokuyama K, Morikawa A, Kuroume T: Distilled water inhalation challenge in asthmatic children. Jpn J Allergol 37:1016-1021 (1988).
16. Shimizu T, Mochizuki H, Morikawa A, Kuroume T: Inhaled furosemide prevents ultrasonically nebulized water bronchoconstriction in children with both atopic and nonatopic asthma. Chest 104:1723-1726 (1993).
17. Nadel JA: Inflammation and asthma. J Allergy Clin Immunol 73:651-653 (1984).
18. O'Byrne PM: Airway inflammation and airway hyperresponsiveness. Chest 90:575-577 (1986).
19. Kato M, Nakano M, Morikawa A, Kimura H, Shigeta M, Kuroume T: Ability of polymorphonuclear leukocytes to generate active oxygen species in children with bronchial asthma: use of chemiluminescence probes with a Cypridina luciferin analog and luminol. Int Arch Allergy Appl Immunol 95:17-22 (1991).
20. O'Byrne PM, Walters EH, Gold BD, Aizawa HA, Fabbri LM, Alpert SE, Nadel JA, Holtzman MJ: Neutrophil depletion inhibits airway hyperresponsiveness induced by ozone exposure. Am Rev Respir Dis 130:214-219 (1984).
21. Kallenbach J, Baynes R, Fine B, Dajee D, Bezwoda W: Persistent neutrophil activation in mild asthma. J Allergy Clin Immunol 90:272-274 (1992).
22. Fahy JV, Kim KW, Liu J, Boushey HA: Prominent neutrophilk inflammation in sputum from subjects with asthma. J Allergy Clin Immunol 95:843-852 (1995).
23. Anderson R: Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation. J Infect Dis 159:966-973 (1989).
24. Labro MT, Benna JE, Babin-Chevaye C: Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neutrophils. J Antimicrob Chemother 24:561-572 (1989).
25. Takei K, Kato M, Mochizuki H, Tokuyama K, Morikawa A, Kuroume T: Effect of roxithromycin on superoxide generation by polymorphoneclear leukocytes from children with bronchial asthma. Jpn J Pediatr Allergy Clin Immunol 9:1-5 (1995).
26. Coleridge JCG, Coleridge HM: Afferent vagal C fibre innervation of lungs and airways and its functional significance. Rev Physiol Biochem Pharmacol 99:1-110 (1984).
27. Sant' Ambrogio G: Afferent pathways for the cough reflex. Bull Eur Physiopathol Respir 23(Suppl 10):19-24s (1987).
28. Fine JM, Gordon T, Thompson JE, Sheppard D: The role of titratable acidity in acid aerosol-induced bronchoconstriction. Am Rev Respir Dis 135:826-830 (1987).
29. Eschenbacher WL, Boushey HA, Sheppard D: Alteration in osmolarity of inhaled aerosols cause broncho constriction and cough, but absence of a permeant anion causes cough alone. Am Rev Respir Dis 129:211- 215 (1984).
30. Allergra L, Bianco S: Non-specific broncho-reactivity obtained with an ultrasonic aerosol of distilled water. Eur J Respir Dis 61(Suppl):41-49 (1980).
31. Schoeffel RE, Andersen SD, Altounyan REC: Bronchial hyperreactivity in response to inhalation of ultrasonically nebulized solutions of distilled water and saline. Br Med J 283:1285-1287 (1981).
32. Goswami SK, Kivity S, Marom Z: Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro. Am Rev Respir Dis 141:72-78 (1990).
33. Marom ZM, Goswami SK: Respiratory mucus hypersecretion (bronchorrhea): A case discussion - Possible mechanism(s) and treatment. J Allergy Clin Immunol 87:1050-1055 (1991).
34. Suga T, Sugiyama Y, Fujii T, Kitamura S: Bronchioloalveolar carcinoma with bronchorrhoea treated with erythromycin. Eur Respir J 7 :2249-2251 (1994).
35. Tamaoki J, Isono K, Sakai N, Kanemura T, Konno K: Erythromycin inhibits C1 secretion across canine tracheal epithelial cells. Eur Respir J 5:234-238 (1992).
36. Bianco S, Vaghi A, Roubushi M, Pasargiklian M: Prevention of exercise-induced bronchoconstriction by inhaled furosemide. Lancet 2:252-255 (1988).
37. Robuschi M, Gambaro G, Spagnotto S, Vaghi A, Bianco S: Inhaled furosemide is highly effective in preventing ultrasonically nebulized water bronchoconstriction. Pulm Pharmacol 1:187-191 (1987).
38. Takeyama K, Tamaoki J, Chiyotani A, Tagaya E, Konno K: Effect of macrolide antibiotics on ciliary motility in rabbit airway epithelium in-vitro. J Pharm Pharmacol 45:756-758 (1993).
39. Tamaoki J, Tagaya E, Sakai A, Konno K: Effects of macrolide antibiotics on neurally mediated contraction of human isolated bronchus. J Allergy Clin Immunol 95:853-859 (1995).
40. Sheppard D, Rizk NW, Boushey HA, Bethel RA: Mechanism of cough and bronchoconstriction induced by distilled water aerosol. Am Rev Respir Dis 127:691-694 (1983).